Park Jae-Keun, Taubenberger Jeffery K
Viral Pathogenesis Section, Laboratory of Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland 20892, United States.
ACS Infect Dis. 2016 Jan 8;2(1):5-7. doi: 10.1021/acsinfecdis.5b00146. Epub 2015 Dec 18.
Influenza viruses are a significant public health threat, causing both annually circulating epidemics and unpredictable pandemics. Vaccination is the best means of control against individual cases of influenza and also for decreasing epidemic spread in the population. However, rapid influenza virus evolution requires continual reformulation of vaccines for annual influenza epidemics, and because pandemics cannot be accurately predicted, no current vaccine strategy can induce broad protection against all subtypes of influenza viruses. Recent work has suggested that such broadly protective, or "universal", influenza virus vaccines might be achievable using vaccine strategies that target conserved B- and T-cell epitopes.
流感病毒是对公众健康的重大威胁,可引发每年季节性流行的疫情以及不可预测的大流行。接种疫苗是预防个体感染流感以及减少人群中流感传播的最佳手段。然而,流感病毒的快速进化要求每年针对流感流行对疫苗进行持续重新配方,而且由于大流行无法准确预测,目前没有疫苗策略能够诱导针对所有流感病毒亚型的广泛保护。最近的研究表明,使用针对保守B细胞和T细胞表位的疫苗策略或许能够实现这种具有广泛保护作用的,即“通用型”流感病毒疫苗。